KBTBD3 Activators
KBTBD3 function through diverse mechanisms to facilitate its activation, primarily by influencing the cellular levels of cyclic AMP (cAMP) and modulating protein kinase A (PKA) activity. Forskolin, a labdane diterpene, directly stimulates adenylyl cyclase, the enzyme responsible for converting ATP to cAMP. This increase in cAMP levels leads to the activation of PKA, which can result in the phosphorylation of KBTBD3. Similarly, IBMX, a non-selective inhibitor of phosphodiesterases, prevents the breakdown of cAMP, thereby sustaining elevated levels of this messenger molecule within the cell, which, in turn, can activate PKA. PKA then acts on KBTBD3 to promote its activation through phosphorylation. Epinephrine and isoproterenol, both catecholamines, engage with adrenergic receptors to trigger a similar cascade of events, leading to adenylyl cyclase activation, cAMP production, PKA activation, and subsequent activation of KBTBD3. Dopamine and salbutamol also activate adenylyl cyclase via their specific G-protein-coupled receptors, leading to PKA-mediated phosphorylation of KBTBD3.
PGE2, glucagon, histamine, and terbutaline interact with their respective G-protein-coupled receptors to elevate cAMP and subsequently activate PKA, which can phosphorylate KBTBD3. Rolipram, by selectively inhibiting phosphodiesterase 4, augments cAMP levels, further facilitating the activation of PKA and the consequent phosphorylation of KBTBD3. Anisomycin, although not directly involved in the cAMP pathway, activates the MAPK pathway, which includes a range of protein kinases capable of phosphorylating and activating KBTBD3. Each of these chemicals, through their interaction with cellular signaling pathways, converges on the activation of PKA or other kinases, which then target KBTBD3 to regulate its activity via phosphorylation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases. By inhibiting these enzymes, IBMX increases intracellular cAMP levels, which can activate PKA, leading to phosphorylation and activation of KBTBD3. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, also known as adrenaline, binds to and activates adrenergic receptors, which can increase cAMP production via adenylyl cyclase activation. Increased cAMP activates PKA, which may then target KBTBD3 for activation through phosphorylation. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G-protein-coupled receptors (GPCRs), potentially leading to the activation of adenylyl cyclase and subsequent increase in cAMP. This rise in cAMP can activate PKA, which might phosphorylate and activate KBTBD3. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to H2 receptors, which are coupled to Gs proteins, leading to an increase in cAMP levels via adenylyl cyclase activation. This increase in cAMP may activate PKA, which could phosphorylate and activate KBTBD3. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can bind to its D1-like receptors, which are coupled to Gs proteins, and stimulate adenylyl cyclase to increase cAMP levels. The resulting activation of PKA could lead to phosphorylation and activation of KBTBD3. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that activates beta-adrenergic receptors, leading to increased cAMP production and PKA activation. PKA may then phosphorylate and activate KBTBD3. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which breaks down cAMP. Inhibition of PDE4 by Rolipram leads to increased cAMP levels, potentially enhancing PKA activity and subsequent KBTBD3 activation. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol is a beta2-adrenergic agonist that can stimulate adenylyl cyclase activity through its receptor, leading to elevated cAMP and activation of PKA, which could target KBTBD3 for activation via phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a pyrrolidine antibiotic that can stimulate MAPK pathways, leading to activation of downstream kinases that may phosphorylate and activate KBTBD3. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline is a beta2-adrenergic receptor agonist that increases cAMP levels by activating adenylyl cyclase, resulting in the activation of PKA which may phosphorylate and thereby activate KBTBD3. | ||||||